An observational study of bevacizumab-induced hypertension as a clinical biomarker of antitumor activity.
Mir O, Coriat R, Cabanes L, Ropert S, Billemont B, Alexandre J, Durand JP, Treluyer JM, Knebelmann B, Goldwasser F
Abstract:
None